Cilostazol API
R&D / Scale-up Phosphodiesterase III Inhibitor & Antiplatelet API
📌 Product Overview
Cilostazol API is under scale-up development for peripheral vascular disease therapies.
✨ Key Features & Quality Advantages
- ✓Polymorph & particle size management
- ✓R&D support package
🔬 Applications & Formulation Uses
- 🔹Antiplatelet and vasodilator formulation trials
🏆 Why Choose PEC Pharma
- 👍Quality-oriented R&D partner
📦 Packaging & Commercial Supply
HDPE drums with inner double polyethylene liners.
📊 Technical Specifications & Quality Metrics
| PARAMETER | SPECIFICATION / RESULT |
|---|---|
| CAS Number | 73963-72-1 |
| Therapeutic Category | Anticoagulant |
| Development Status | Under Scale-Up / R&D |
❓ Frequently Asked Questions (Cilostazol API)
What is the CAS Registry Number of Cilostazol API?
The CAS Registry Number for Cilostazol API is 73963-72-1. Synonyms include Pletal API, CAS 73963-72-1.
Who is a reliable GMP manufacturer and supplier of Cilostazol API in India?
PEC Pharma (PeriEleChem Pharma Pvt. Ltd.) is a leading GMP-certified manufacturer and supplier of Cilostazol API (CAS 73963-72-1) with commercial facilities in Vadodara and GIDC Saykha, Gujarat, India.
What compendial standards does Cilostazol API meet?
Cilostazol API API supplied by PEC Pharma complies with USP / JP Under Scale-up quality monographs. Official Certificate of Analysis (COA) PDF and regulatory documentation (DMF) support are available for commercial batches.
How can I download the Certificate of Analysis (COA) or request a bulk quote for Cilostazol API?
You can submit a commercial quotation request form directly on this page to receive instant batch technical data, pricing, and official Certificate of Analysis (COA) from PEC Pharma.
